Abstract
Fibromyalgia syndrome (FMS) frequently presents with autonomic and/or functional symptoms. Tropisetron, a selective serotonin-3 antagonist, is widely used for the treatment of this disease. However, its effects on autonomic function are not well known. In the present study, we evaluated whether tropisetron improved cardiac autonomic symptoms in FMS. Thirty-six patients were treated with physiotherapy and 5 mg tropisetron intravenously for 5 days. An additional 36 patients were treated with physiotherapy alone. Thirty-six volunteers served as healthy controls. The ISAX apparatus was used for spectral analyses of cardiac R–R intervals. High frequencies and mid frequencies were analysed to assess sympathetic and parasympathetic activity. The findings were correlated with pain intensity. ISAX findings were significantly different in FMS patients compared to healthy controls and did not correlate with pain perception. Ten of 12 pathological parameters disappeared during treatment in the tropisetron group. Our results indicate that tropisetron reduced not only pain perception but also had a favourable effect on cardiac dysfunction during treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Müller W, Lautenschläger J (1990) Generalized tendomyopathy II: pathogenesis and therapy. Z Rheumatol 49:22–29
Martínez Lavín M, Hermosillo AG (2000) Autonomic nervous system dysfunction may explain the multisystem features of fibromyalgia. Semin Arthritis Rheum 29:197–199
Cohen H, Neumann L, Shore M, Amir M, Cassuto Y, Buskila D (2000) Autonomic dysfunction in patients with fibromyalgia: application of power spectral analysis of heart rate variability. Semin Arthritis Rheum 29:217–227
Lang E, Caminal P, Horvath G, Jane R, Vallverdu M, Slezsak J, Bayes de Luna A (1998) Spectral analysis of the heart period variance (HVP): a tool to stratify risk following myocardial infarction. J Med Eng Technol 22:248–256
Haus U, Varga B, Stratz T, Späth M, Müller W (2000) Oral treatment of fibromyalgia with tropisetron given over 28 days: influence on functional and vegetative symptoms, psychometric parameters and pain. Scand J Rheumatol Suppl 113:55–58
Müller W, Stratz T (2000) The use of 5-HT3 receptor antagonists in various rheumatic diseases: a clue to the mechanism of action of these agents in fibromyalgia. Scand J Rheumatol Suppl 113:66–71
Färber L, Stratz TH, Bruckle W, Späth M, Pongratz D, Lautenschläger J, Kotter I, Zoller B, Peter HH, Neeck G, Welzel D, Müller W, German Fibromyalgia Study Group (2001) Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patients. Int J Clin Pharmacol Res 21:1–13
Späth M, Stratz T, Neeck G, Kotter I, Hammel B, Amberger CC, Haus U, Färber L, Pongratz D, Müller W (2004) Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia. Scand J Rheumatol 33:267–270
Seidel MF, Koch FW, Vetter H (2006) Macrophage like synoviocytes display phenotypic polymorphisms in a serum free tissue culture medium. Rheumatol Int 26:244–251
Seidel MF, Ulrich Merzenich G, Fiebich B, Candelario Jalil E, Koch FW, Vetter H (2004) Tropisetron inhibits serotonin-induced PGE2 release from macrophage-like synovial cells in serum-free tissue culture. Scand J Rheumatol Suppl 119:33
Fiebich BL, Akundi RS, Lieb K, Candelario Jalil E, Gmeiner D, Haus U, Müller W, Stratz T, Munoz E (2004) Antiinflammatory effects of 5-HT3 receptor antagonists in lipopolysaccharide stimulated primary human monocytes. Scand J Rheumatol Suppl 119:28–32
Samborski W, Atarowska M, Stratz T et al (2003) Intraarticular tropisentron compared with ethylprednisolone acetate in knee involvement in osteoarthritis and rheumatiod arthritis. Preliminary report. Ann Rheum Dis 62:405
Voog U, Alstergren P, Leibur E, Kallikorm R, Kopp S (2004) Influence of serotonin on the analgesic effect of granisetron on temporomandibular joint arthritis. Mediators Inflamm 13:373–376
Wolfe F, Smythe HA, Yunus MB, Bennett RM et al (1990) The american college of rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33:160–172
Lautenschläger J, Seglias J, Bruckle W, Müller W (1991) Comparisons of spontaneous pain and tenderness in patients with primary fibromyalgia. Clin Rheumatol 10:168–173
Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, Cohen RJ (1981) Spectrum analysis of heart rate fluctuation: a quantitative probe of beat to beat cardiovascular control. Science 10:220–222
Lang E, Szilagyi N (1991) Significance and assessment of autonomic indices in cardiovascular reactions. Acta Physiol Hung 78:241–260
Izso L, Lang E (2000) Heart period variability as mental effort monitor in human computer interaction. Behav Inf Technol 19:297–306
Kelemen J, Trocsanyi M, Lang E, Müller W (2000) The effect of whole body cold treatment on the autonomic nervous system studied by power spectral analysis of heart period variance. J Musculoskelet pain 6:136
Kelemen J, Lang E, Balint G, Trocsanyi M, Müller W (1998) Orthostatic sympathetic derangement of baroreflex in patients with fibromyalgia. J Rheumatol 25:823–825
Martinez Lavin M, Hermosillo AG, Rosas M, Soto ME (1998) Circadian studies of autonomic nervous balance in patients with fibromyalgia: a heart rate variability analysis. Arthritis Rheum 41:1966–1971
Furlan R, Colombo S, Perego F, Atzeni F, Diana A, Barbic F, Porta A, Pace F, Malliani A, Sarzi Puttini P (2005) Abnormalities of cardiovascular neural control and reduced orthostatic tolerance in patients with primary fibromyalgia. J Rheumatol 32:1787–1793
Müller W, Lautenschläger J (1990) Generalized tendomyopathy I: clinical aspects, follow up and differential diagnosis. Z Rheumatol 49:11–21
Acknowledgments
The authors thank Professor Dr. E. Lang for the introduction to the ISAX technique and Dr. Rolf Fimmers for his statistical advice. We also thank Mrs. Gabriele Mehrer and Mr. Hussam Hamou for their assistance in manuscript preparation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Seidel, M.F., Weinreich, G.F., Stratz, T. et al. 5-HT3 receptor antagonists regulate autonomic cardiac dysfunction in primary fibromyalgia syndrome. Rheumatol Int 27, 1025–1030 (2007). https://doi.org/10.1007/s00296-007-0406-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-007-0406-6